Dr. Greenamyre is Chair of the Parkinson’s Foundation Scientific Advisory Board (SAB) and a scientific advisor to the Michael J. Fox Foundation and the American Parkinson Disease Association. He completed his M.D., Ph.D. and residency training in Neurology at the University of Michigan. He has been listed as one of the ‘Best Doctors in America’ since the mid-1990s. Dr. Greenamyre's laboratory studies mechanisms of neurodegeneration in Parkinson’s disease, with a focus on gene-environment interactions. Translational studies use pharmacological and ‘gene therapy’ approaches. He was Chair of the 2019 Parkinson’s Disease Gordon Research Conference. He is editor-in-chief of the scientific journal Neurobiology of Disease, a member of the SAB of Science Translational Medicine and he serves on other editorial boards.